Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave ...
January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...
South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said ...
Social disruption from the COVID-19 pandemic is linked to increased odds of substance use in adolescents with chronic pain.
Additional funding of $20 million accelerates commercialization of Trailhead's iPSC-derived human cell and media products.
To celebrate the integration between Firefly and GPT-Image 1.5, Pro and Premium subscribers can generate unlimited images until January 15.
One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...
Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...
Morning Overview on MSN
The most ridiculous fake car features hiding in today’s models
Modern cars are packed with more computing power and safety tech than ever, yet some of the flashiest “innovations” are ...
Pharmaceutical Technology on MSN
JPM26: Eli Lilly and NVIDIA deepen ties with $1bn AI partnership
A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel ...
Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...
AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results